MENS
Jyong Biotech Ltd. Ordinary Shares
NASDAQ: MENS · HEALTHCARE · BIOTECHNOLOGY
$2.18
+0.46% today
Updated 2026-04-29
Market cap
$164.98M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.04
Dividend yield
—
52W range
$1 – $67
Volume
0.2M
Jyong Biotech Ltd. Ordinary Shares (MENS) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | $12.84M | $9.43M | $8.74M | $8.25M | $6.37M |
| Cash & equivalents | $3.56M | $551000.00 | $718000.00 | $177000.00 | $98000.00 |
| Current assets | $6.22M | $2.65M | $2.46M | $1.84M | $206000.00 |
| Total liabilities | $32.05M | $32.76M | $38.38M | $42.32M | $42.88M |
| Current liabilities | $5.78M | $6.29M | $12.91M | $14.26M | $12.13M |
| Long-term debt | — | $6.26M | $6.32M | $8.52M | $10.68M |
| Shareholder equity | $-19.20M | $-23.32M | $-29.63M | $-34.07M | $-36.52M |
| Retained earnings | $-14.83M | $-19.03M | $-25.66M | $-30.06M | $-33.08M |
| Accounts receivable | — | — | — | — | — |
| Inventory | — | — | — | — | — |
| Goodwill | — | — | — | — | — |